No photo of John W Regan

View Scopus Profile

John W Regan

  • 8748 Citations
  • 48 h-Index
1974 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where John W Regan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

ALPHA 2 AND PROSTAGLANDIN RECEPTORS IN EYE

Regan, J. W.

National Institutes of Health

4/1/97 → 3/31/08

Project: Research project

    • CLONING AND MUTAGENESIS OF A2 - ADRENERGIC RECEPTORS

    Regan, J. W.

    National Institutes of Health

    4/1/91 → 3/31/97

    Project: Research project

    • Research Output

    Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP 4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells

    Kurata, N., Tokashiki, N., Fukushima, K., Misao, T., Hasuoka, N., Kitagawa, K., Mashimo, M., Regan, J. W., Murayama, T. & Fujino, H., Jun 15 2019, In : European Journal of Pharmacology. 853, p. 308-315 8 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding region

    Seira, N., Yamagata, K., Fukushima, K., Araki, Y., Kurata, N., Yanagisawa, N., Mashimo, M., Nakamura, H., Regan, J. W., Murayama, T. & Fujino, H., Dec 1 2018, In : Pharmacology research & perspectives. 6, 6, p. e00441

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Anti-cancer effects of MW-03, a novel indole compound, by inducing 15-hydroxyprostaglandin dehydrogenase and cellular growth inhibition in the ls174t human colon cancer cell line

    Seira, N., Yanagisawa, N., Suganami, A., Honda, T., Wasai, M., Regan, J. W., Fukushima, K., Yamaguchi, N., Tamura, Y., Arai, T., Murayama, T. & Fujino, H., 2017, In : Biological and Pharmaceutical Bulletin. 40, 10, p. 1806-1812 7 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    PGE1 and E3 show lower efficacies than E2 to β-catenin-mediated activity as biased ligands of EP4 prostanoid receptors

    Araki, Y., Suganami, A., Endo, S., Masuda, Y., Fukushima, K., Regan, J. W., Murayama, T., Tamura, Y. & Fujino, H., Nov 2017, In : FEBS Letters. 591, 22, p. 3771-3780 10 p.

    Research output: Contribution to journal › Letter

    • 5 Scopus citations

    Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands

    Suganami, A., Fujino, H., Okura, I., Yanagisawa, N., Sugiyama, H., Regan, J. W., Tamura, Y. & Murayama, T., Nov 1 2016, In : FEBS Journal. 283, 21, p. 3931-3940 10 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations